Screening, prevalence, awareness, treatment, and control of hypertension, dyslipidemia and diabetes in Mexican adults. Ensanut 2022.

Objective. To describe the estimates of screening, prevalence, previous diagnosis, treatment and control of hypertension, hypercholesterolemia and diabetes, as well as their associated factors in Mexican adults. Materials and methods. Information from adults aged 20 years and over participating in the Encuesta Nacional de Salud y Nutricion 2022 (Ensanut 2022) was used. Prevalence estimates are presented with their 95% confidence intervals, and multiple logistic regression models for each condition, with factors associated with screening, awareness, treatment, and control. Results. Screening for these three diseases is low, less than 15%. The prevalence of hypercholesterolemia and diabetes is 18% and prevalence of hypertension is 27.6%; about half know their diagnosis.The proportion of patients with pharmacological treatment has increased, but less than a half of them are in control. Conclusion. It is recommended that the detection of these diseases be done in an integrated way with other cardiovascular risk factors. It is necessary to increase the percentages of screening, increase the awareness, improve the percentage of medical treatment for these diseases, and above all increase the proportion of patients in treatment with metabolic control.